Category : Search result: Eli Cohen


Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk

Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.

Steve Cohen's $2.4B Mets Ownership Era Explained

Explore how billionaire Steve Cohen's record $2.4 billion purchase of the New York Mets in 2020 is transforming the team's future with massive spending and a hands-on approach. Discover the financial power behind the club's new era.

Alzheimer's Drug Donanemab Approved in India

Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.

Alzheimer's Drug Donanemab Approved for India

Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.

Trump: Deal Reached to Lower Weight Loss Drug Prices

Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.

Israel-India Strengthen Ties Against Terrorism Threat

Israel's Foreign Minister Eli Cohen emphasizes growing strategic partnership with India, highlighting shared terrorism threats and expanding cooperation in defense, technology, and agriculture during crucial diplomatic meetings.

Page 1 of 2